CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
Valencia, Spain and 123 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Valencia, Spain and 209 other locations
over time. The third main question is to see if ELVN-002 works to shrink cancers that have HER2 genetic abnormalities, particularly non...
Phase 1
Valencia, Spain and 38 other locations
medicinal product\]) in patients with advanced or metastasized non-small cell lung cancer (NSCLC) and...
Phase 1
Valencia, Spain and 37 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung...
Phase 2
Valencia, Spain and 138 other locations
PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....
Phase 2
Valencia, Spain and 126 other locations
"study drugs". The study is focused on patients who have advanced non-small cell lung cancer (NSCLC).The...
Phase 2
Valencia, Spain and 54 other locations
in participants with Programmed death ligand-1 (PD L-1) high (Tumor cells \[TC\]/ Tumor proportion score \[TPS\] \>= 50%),-...
Phase 2
Valencia, Spain and 110 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Valencia, Spain and 252 other locations
and safety of osimertinib following chemoradiation in patients with stage III unresectable Epidermal Growth Factor Receptor Mutation Positive non...
Phase 3
Valencia, Spain and 118 other locations
Clinical trials
Research sites
Resources
Legal